Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hitomi, Sawa"'
Autor:
Shuto, Negishi, Kotaro, Miyao, Fumiya, Ohara, Kenta, Motegi, Hiroya, Wakabayashi, Hirofumi, Yokota, Shihomi, Kuwano, Yuki, Takeuchi, Hitomi, Sawa, Yuichiro, Inagaki, Masashi, Sawa
Publikováno v:
Clinical and Experimental Medicine.
The effectiveness and safety of trimethoprim/sulfamethoxazole (TMP/SMX) desensitization therapy is insufficiently evaluated in hematological diseases. From 2002 to 2019, we retrospectively analyzed 112 patients with hematological diseases who underwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2038f6014564d635c0837e133a612108
https://doi.org/10.1007/s10238-022-00868-3
https://doi.org/10.1007/s10238-022-00868-3
Autor:
Yuki Takeuchi, Kotaro Miyao, Shuto Negishi, Fumiya Ohara, Kenta Motegi, Hiroya Wakabayashi, Hirofumi Yokota, Shihomi Kuwano, Hitomi Sawa, Yuichiro Inagaki, Masashi Sawa
Publikováno v:
Transplantation and Cellular Therapy. 29:325.e1-325.e10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d88968c36f979754f48410eaec4bf2f3
https://doi.org/10.1016/j.jtct.2023.01.026
https://doi.org/10.1016/j.jtct.2023.01.026
Autor:
Yuichiro Inagaki, Syuto Negishi, Hirofumi Yokota, Hitomi Sawa, Kotaro Miyao, Kosuke Takahashi, Junko Arima, Masashi Sawa
Publikováno v:
Annals of Oncology. 33:S528
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::732621093cffa380cbf67a022c002f0b
https://doi.org/10.1016/j.annonc.2022.05.293
https://doi.org/10.1016/j.annonc.2022.05.293
Autor:
Toshiyasu Sakai, Hitomi Sawa, Tomonori Kato, Yoshihide Kakimoto, Yuichiro Inagaki, Kanae Imai, Masashi Sawa
Publikováno v:
Journal of Hematopoietic Cell Transplantation. 7:82-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ed1d52ba4e6d223be7a2ea662b7531c
https://doi.org/10.7889/hct-17-008
https://doi.org/10.7889/hct-17-008
Autor:
Masashi Sawa, Seki Takashi, Kotaro Miyao, Yuichiro Inagaki, Eiji Yoneyama, Yuki Takeuchi, Junko Arima, Fumiya Ohara, Hirofumi Yokota, Hitomi Sawa
Publikováno v:
Annals of Oncology. 32:S344
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81fcf964e5f25af64326c41abac83152
https://doi.org/10.1016/j.annonc.2021.05.726
https://doi.org/10.1016/j.annonc.2021.05.726
Autor:
Tomonori Kato, Hitomi Sawa, Shihomi Kuwano, Hirofumi Yokota, Yuki Takeuchi, Masashi Sawa, Kanae Imai, Yuichiro Inagaki
Publikováno v:
Annals of Oncology. 30:vi122-vi123
Background The prognosis of CML has dramatically improved with the introduction of imatinib. Patients diagnosed in chronic phase can live almost as long time as healthy people. However, adequate strategy of pregnancy under TKI treatment has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f311c6434c53e2e190052ab91dd1ca9
https://doi.org/10.1093/annonc/mdz343.022
https://doi.org/10.1093/annonc/mdz343.022
Autor:
Kenta Motegi, Hiroya Wakabayashi, Fumiya Ohara, Yuki Takeuchi, Hirofumi Yokota, Hitomi Sawa, Masashi Sawa, Kotaro Miyao, Shihomi Kuwano, Yuichiro Inagaki
Publikováno v:
Blood. 134:1611-1611
Introduction The prognosis of primary central nervous system lymphoma (PCNSL) has improved with the introduction of high-dose methotrexate (HD-MTX)-based chemotherapeutic regimens. However, the optimal consolidation therapy is still uncertain. From t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d083fcf847d0e1fa1517d3e144fbdc68
https://doi.org/10.1182/blood-2019-123703
https://doi.org/10.1182/blood-2019-123703
Autor:
Hidetoshi Akita, Yuki Takeuchi, Hitomi Sawa, Mamiko Takeuchi, Yuichiro Inagaki, Shoji Mitsuya, Takashi Seki, Eiji Yoneyama, Junko Arima, Masashi Sawa, Hirofumi Yokota
Publikováno v:
Annals of Oncology. 30:vi135
Background Nivolmab is approved as a novel immunocheckpoint inhibitor and peculiar immune-related adverse events (irAE) including interstitial lung disease (ILD), endocrinological disorder, and immunological colitis are reported. The rapid diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1239b24aa5e25ff25883799acb101791
https://doi.org/10.1093/annonc/mdz343.079
https://doi.org/10.1093/annonc/mdz343.079
Autor:
Shihomi Kuwano, Kotaro Miyao, Hitomi Sawa, Hirofumi Yokota, Yuichiro Inagaki, Yuki Takeuchi, Masashi Sawa
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06ff50b10439d1ab71f143daf20fff77
https://doi.org/10.1016/j.clml.2019.07.184
https://doi.org/10.1016/j.clml.2019.07.184
Autor:
Tomonori Kato, Hirofumi Yokota, Yuki Takeuchi, Masashi Sawa, Hitomi Sawa, Yuichiro Inagaki, Eiji Yoneyama, Junko Arima, Kanae Imai, Shihomi Taniyama
Publikováno v:
Annals of Oncology. 29:vii59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c667012703065c446407d9ce1ec08ade
https://doi.org/10.1093/annonc/mdy374.036
https://doi.org/10.1093/annonc/mdy374.036